← Back to all trials
Recruiting
NCT05999994
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Conditions: Neoplasms, Child, Adolescent
Sex: All
Ages: 1 Year – 39 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 105
Sponsor: Eli Lilly and Company
Location: Childrens Hospital of Alabama Birmingham Alabama
Summary
The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under this master protocol define drug/disease-specific research goals and activities to test them. New studies will be added as new drugs emerge against different cancers. Participation in the trial will depend on how long the benefit lasts.
Eligibility Criteria
Inclusion Criteria:
Participants must meet all of the inclusion criteria below. Additional criteria are specified in the protocol amendment (individual addenda) to which the participant will enroll.
* Have either measurable or evaluable disease using standard techniques by the Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST 1.1).
* The participant has a Lansky (\
Source: ClinicalTrials.gov (NCT05999994). StuddyBuddy aggregates publicly available trial information.
